Cocrystal pharma reports 2021 financial results and provides updates on development programs and milestones

Bothell, wash., march 23, 2022 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp) reports financial results for the 12 months ended december 31, 2021, and provides updates on its antiviral pipeline, upcoming milestones and business activities.

COCP Ratings Summary

COCP Quant Ranking